Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CCK
CCK logo

CCK Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Crown Holdings Inc (CCK) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
105.170
1 Day change
1.00%
52 Week Range
116.620
Analysis Updated At
2026/03/13
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Crown Holdings Inc (CCK) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock is currently oversold, but the lack of strong positive catalysts, mixed analyst ratings, and weak financial performance make it prudent to hold off on buying until clearer growth signals emerge.

Technical Analysis

The stock is currently oversold with an RSI of 15.446, indicating potential for a rebound. However, the MACD is negative (-1.442) and contracting, suggesting bearish momentum. The stock is trading near its S1 support level of 104.134, with resistance at 109.326. Moving averages are converging, indicating indecision in price direction.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The high option volume put-call ratio (1.75) suggests bearish sentiment in the options market, while the open interest put-call ratio (0.55) indicates more calls than puts in open contracts.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
8

Positive Catalysts

  • Analysts from RBC Capital, Truist, Morgan Stanley, and Mizuho have raised their price targets, citing strong fundamentals and potential for North American volume growth. The company has guided to in-line FY26 performance and continues to execute well despite cost pressures.

Neutral/Negative Catalysts

  • Hedge funds are selling, with a 707.29% increase in selling activity last quarter. Insider trading is neutral, and there is no significant congress trading data. Financial performance in Q4 2025 showed a sharp decline in net income (-58.10% YoY) and EPS (-56.62% YoY), with gross margin also contracting. UBS and JPMorgan downgraded the stock, citing valuation concerns and limited near-term growth potential.

Financial Performance

In Q4 2025, revenue increased by 7.72% YoY to $3.127 billion. However, net income dropped significantly by 58.10% YoY to $150 million, and EPS declined by 56.62% to 1.31. Gross margin also contracted by 7.18% to 17.46%, reflecting cost pressures.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is mixed. While several firms (e.g., RBC Capital, Truist, Morgan Stanley) raised price targets and maintained positive ratings, others (e.g., UBS, JPMorgan, Wolfe Research) downgraded the stock due to valuation concerns and limited near-term growth potential. The current price is near the lower end of the revised targets, with an average target of approximately $125.

Wall Street analysts forecast CCK stock price to rise
12 Analyst Rating
Wall Street analysts forecast CCK stock price to rise
7 Buy
5 Hold
0 Sell
Moderate Buy
Current: 104.130
sliders
Low
106
Averages
127.25
High
142
Current: 104.130
sliders
Low
106
Averages
127.25
High
142
RBC Capital
Outperform
maintain
$120 -> $140
AI Analysis
2026-02-09
Reason
RBC Capital
Price Target
$120 -> $140
AI Analysis
2026-02-09
maintain
Outperform
Reason
RBC Capital raised the firm's price target on Crown Holdings to $140 from $120 and keeps an Outperform rating on the shares. The company beat Q4 on solid volumes and guided to an in-line FY26 on continued strong execution, the analyst tells investors in a research note. Crown could see 2%-3% North America volume growth and improved FY27 earnings growth as it manages through 2026 labor and energy cost pressure, the firm added.
UBS
Buy -> Neutral
downgrade
$126
2026-02-09
Reason
UBS
Price Target
$126
2026-02-09
downgrade
Buy -> Neutral
Reason
UBS downgraded Crown Holdings to Neutral from Buy with an unchanged price target of $126. The firm sees a more balanced risk/reward with the shares nearing the price target. Crown may see a multi-year period of lower volume drop as new capacity is needed to service demand, the analyst tells investors in a research note. The firm says the company's incremental growth is less accretive in the near term as its investments pick up.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CCK
Unlock Now

People Also Watch